ID CAF1B_HUMAN Reviewed; 559 AA. AC Q13112; Q99548; DT 15-JUL-1998, integrated into UniProtKB/Swiss-Prot. DT 01-NOV-1996, sequence version 1. DT 28-JAN-2026, entry version 232. DE RecName: Full=Chromatin assembly factor 1 subunit B {ECO:0000305}; DE Short=CAF-1 subunit B; DE AltName: Full=Chromatin assembly factor I p60 subunit; DE Short=CAF-I 60 kDa subunit; DE Short=CAF-I p60; DE AltName: Full=M-phase phosphoprotein 7; GN Name=CHAF1B {ECO:0000312|HGNC:HGNC:1911}; GN Synonyms=CAF1A, CAF1P60, MPHOSPH7, MPP7; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA], AND PROTEIN SEQUENCE OF 100-123. RX PubMed=7600578; DOI=10.1016/s0092-8674(05)80015-7; RA Kaufman P.D., Kobayashi R., Kessler N., Stillman B.; RT "The p150 and p60 subunits of chromatin assembly factor I: a molecular link RT between newly synthesized histones and DNA replication."; RL Cell 81:1105-1114(1995). RN [2] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RA Shibuya K., Kudoh J., Minoshima S., Kawasaki K., Nakatoh E., Shintani A., RA Asakawa S., Shimizu N.; RT "Genomic sequencing of 1.2-Mb region on human chromosome 21q22.2."; RL Submitted (NOV-1999) to the EMBL/GenBank/DDBJ databases. RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=10830953; DOI=10.1038/35012518; RA Hattori M., Fujiyama A., Taylor T.D., Watanabe H., Yada T., Park H.-S., RA Toyoda A., Ishii K., Totoki Y., Choi D.-K., Groner Y., Soeda E., Ohki M., RA Takagi T., Sakaki Y., Taudien S., Blechschmidt K., Polley A., Menzel U., RA Delabar J., Kumpf K., Lehmann R., Patterson D., Reichwald K., Rump A., RA Schillhabel M., Schudy A., Zimmermann W., Rosenthal A., Kudoh J., RA Shibuya K., Kawasaki K., Asakawa S., Shintani A., Sasaki T., Nagamine K., RA Mitsuyama S., Antonarakis S.E., Minoshima S., Shimizu N., Nordsiek G., RA Hornischer K., Brandt P., Scharfe M., Schoen O., Desario A., Reichelt J., RA Kauer G., Bloecker H., Ramser J., Beck A., Klages S., Hennig S., RA Riesselmann L., Dagand E., Wehrmeyer S., Borzym K., Gardiner K., RA Nizetic D., Francis F., Lehrach H., Reinhardt R., Yaspo M.-L.; RT "The DNA sequence of human chromosome 21."; RL Nature 405:311-319(2000). RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Uterus; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [5] RP NUCLEOTIDE SEQUENCE [MRNA] OF 474-559, AND PHOSPHORYLATION. RC TISSUE=Lymphoblast; RX PubMed=8885239; DOI=10.1091/mbc.7.9.1455; RA Matsumoto-Taniura N., Pirollet F., Monroe R., Gerace L., Westendorf J.M.; RT "Identification of novel M phase phosphoproteins by expression cloning."; RL Mol. Biol. Cell 7:1455-1469(1996). RN [6] RP FUNCTION. RX PubMed=9813080; DOI=10.1083/jcb.143.3.563; RA Martini E., Roche D.M., Marheineke K., Verreault A., Almouzni G.; RT "Recruitment of phosphorylated chromatin assembly factor 1 to chromatin RT after UV irradiation of human cells."; RL J. Cell Biol. 143:563-575(1998). RN [7] RP SUBCELLULAR LOCATION, AND PHOSPHORYLATION. RX PubMed=9614144; DOI=10.1074/jbc.273.24.15279; RA Marheineke K., Krude T.; RT "Nucleosome assembly activity and intracellular localization of human CAF-1 RT changes during the cell division cycle."; RL J. Biol. Chem. 273:15279-15286(1998). RN [8] RP REVIEW. RX PubMed=10893180; DOI=10.1242/jcs.113.15.2647; RA Ridgway P., Almouzni G.; RT "CAF-1 and the inheritance of chromatin states: at the crossroads of DNA RT replication and repair."; RL J. Cell Sci. 113:2647-2658(2000). RN [9] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Cervix carcinoma; RX PubMed=17081983; DOI=10.1016/j.cell.2006.09.026; RA Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.; RT "Global, in vivo, and site-specific phosphorylation dynamics in signaling RT networks."; RL Cell 127:635-648(2006). RN [10] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Cervix carcinoma; RX PubMed=16964243; DOI=10.1038/nbt1240; RA Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.; RT "A probability-based approach for high-throughput protein phosphorylation RT analysis and site localization."; RL Nat. Biotechnol. 24:1285-1292(2006). RN [11] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Cervix carcinoma; RX PubMed=18220336; DOI=10.1021/pr0705441; RA Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., Yates J.R. III; RT "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient RT phosphoproteomic analysis."; RL J. Proteome Res. 7:1346-1351(2008). RN [12] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-419; SER-429; THR-433 AND RP SER-538, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Cervix carcinoma; RX PubMed=18669648; DOI=10.1073/pnas.0805139105; RA Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., RA Elledge S.J., Gygi S.P.; RT "A quantitative atlas of mitotic phosphorylation."; RL Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). RN [13] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=19413330; DOI=10.1021/ac9004309; RA Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.; RT "Lys-N and trypsin cover complementary parts of the phosphoproteome in a RT refined SCX-based approach."; RL Anal. Chem. 81:4493-4501(2009). RN [14] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-429, AND IDENTIFICATION BY RP MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Leukemic T-cell; RX PubMed=19690332; DOI=10.1126/scisignal.2000007; RA Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K., RA Rodionov V., Han D.K.; RT "Quantitative phosphoproteomic analysis of T cell receptor signaling RT reveals system-wide modulation of protein-protein interactions."; RL Sci. Signal. 2:RA46-RA46(2009). RN [15] RP ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-494, AND IDENTIFICATION BY MASS RP SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=19608861; DOI=10.1126/science.1175371; RA Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C., RA Olsen J.V., Mann M.; RT "Lysine acetylation targets protein complexes and co-regulates major RT cellular functions."; RL Science 325:834-840(2009). RN [16] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-409 AND SER-458, AND RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Cervix carcinoma; RX PubMed=20068231; DOI=10.1126/scisignal.2000475; RA Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L., RA Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.; RT "Quantitative phosphoproteomics reveals widespread full phosphorylation RT site occupancy during mitosis."; RL Sci. Signal. 3:RA3-RA3(2010). RN [17] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=21269460; DOI=10.1186/1752-0509-5-17; RA Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., RA Bennett K.L., Superti-Furga G., Colinge J.; RT "Initial characterization of the human central proteome."; RL BMC Syst. Biol. 5:17-17(2011). RN [18] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-458, AND IDENTIFICATION BY RP MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=21406692; DOI=10.1126/scisignal.2001570; RA Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T., RA Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.; RT "System-wide temporal characterization of the proteome and phosphoproteome RT of human embryonic stem cell differentiation."; RL Sci. Signal. 4:RS3-RS3(2011). RN [19] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-394; THR-419; SER-429; RP THR-433 AND SER-458, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE RP ANALYSIS]. RC TISSUE=Cervix carcinoma, and Erythroleukemia; RX PubMed=23186163; DOI=10.1021/pr300630k; RA Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J., RA Mohammed S.; RT "Toward a comprehensive characterization of a human cancer cell RT phosphoproteome."; RL J. Proteome Res. 12:260-271(2013). RN [20] RP INTERACTION WITH HISTONES H3.1; H3.2 AND H3.1T. RX PubMed=33857403; DOI=10.1016/j.molcel.2021.03.041; RA Hammond C.M., Bao H., Hendriks I.A., Carraro M., Garcia-Nieto A., Liu Y., RA Reveron-Gomez N., Spanos C., Chen L., Rappsilber J., Nielsen M.L., RA Patel D.J., Huang H., Groth A.; RT "DNAJC9 integrates heat shock molecular chaperones into the histone RT chaperone network."; RL Mol. Cell 0:0-0(2021). CC -!- FUNCTION: Acts as a component of the histone chaperone complex CC chromatin assembly factor 1 (CAF-1), which assembles histone octamers CC onto DNA during replication and repair. CAF-1 performs the first step CC of the nucleosome assembly process, bringing newly synthesized histones CC H3 and H4 to replicating DNA; histones H2A/H2B can bind to this CC chromatin precursor subsequent to DNA replication to complete the CC histone octamer. {ECO:0000269|PubMed:9813080}. CC -!- SUBUNIT: Subunit of the CAF-1 complex that contains RBBP4, CHAF1B and CC CHAF1A. CHAF1A binds directly to CHAF1B. Only minor amounts of RBBP4 CC are complexed with CHAF1A and CHAF1B in G1 phase. In G2 and S phase CC also monomeric CHAF1B is detected. Interacts with histones H3.1, H3.2 CC and H3.1t (PubMed:33857403). {ECO:0000250|UniProtKB:Q5R1S9, CC ECO:0000269|PubMed:33857403}. CC -!- INTERACTION: CC Q13112; Q9Y294: ASF1A; NbExp=3; IntAct=EBI-1052944, EBI-749553; CC Q13112; Q9NVP2: ASF1B; NbExp=7; IntAct=EBI-1052944, EBI-1055650; CC -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:9614144}. Cytoplasm CC {ECO:0000269|PubMed:9614144}. Note=DNA replication foci. Cytoplasmic in CC M phase. CC -!- DEVELOPMENTAL STAGE: Active complex is found in G1, S and G2 phases. CC -!- PTM: Differentially phosphorylated during cell cycle. During mitosis CC the p60 subunit of inactive CAF-1 is hyperphosphorylated and displaced CC into the cytosol. Progressivly dephosphorylated from G1 to S and G2 CC phase. Phosphorylated p60 is recruited to chromatin undergoing DNA CC repair after UV irradiation in G1, S or G2 phases. CC {ECO:0000269|PubMed:8885239, ECO:0000269|PubMed:9614144}. CC -!- SIMILARITY: Belongs to the WD repeat HIR1 family. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; U20980; AAA76737.1; -; mRNA. DR EMBL; AP000694; BAA89426.1; -; Genomic_DNA. DR EMBL; AP001725; BAA95549.1; -; Genomic_DNA. DR EMBL; BC021218; AAH21218.1; -; mRNA. DR EMBL; X98262; CAA66915.1; -; mRNA. DR CCDS; CCDS13644.1; -. DR PIR; B56731; B56731. DR RefSeq; NP_005432.1; NM_005441.3. DR PDB; 7Y5K; X-ray; 3.48 A; B=1-419. DR PDB; 7Y5L; X-ray; 3.42 A; B/E=1-419. DR PDB; 7Y5O; X-ray; 3.57 A; B/E=1-419. DR PDB; 7Y5U; EM; 3.80 A; B=1-419. DR PDB; 7Y5V; EM; 6.10 A; B/G=1-419. DR PDB; 7Y60; EM; 3.80 A; L=1-419. DR PDB; 7Y61; EM; 5.60 A; L/N=1-419. DR PDB; 8IQF; EM; 4.60 A; B/G=1-559. DR PDB; 8IQG; EM; 3.50 A; B=1-559. DR PDB; 8J6S; EM; 3.80 A; L=1-559. DR PDB; 8J6T; EM; 6.60 A; L/N=1-559. DR PDBsum; 7Y5K; -. DR PDBsum; 7Y5L; -. DR PDBsum; 7Y5O; -. DR PDBsum; 7Y5U; -. DR PDBsum; 7Y5V; -. DR PDBsum; 7Y60; -. DR PDBsum; 7Y61; -. DR PDBsum; 8IQF; -. DR PDBsum; 8IQG; -. DR PDBsum; 8J6S; -. DR PDBsum; 8J6T; -. DR AlphaFoldDB; Q13112; -. DR EMDB; EMD-33625; -. DR EMDB; EMD-33626; -. DR EMDB; EMD-33630; -. DR EMDB; EMD-33631; -. DR EMDB; EMD-35660; -. DR EMDB; EMD-35661; -. DR EMDB; EMD-36013; -. DR EMDB; EMD-36014; -. DR SMR; Q13112; -. DR BioGRID; 113846; 179. DR ComplexPortal; CPX-569; Chromatin assembly factor 1 complex. DR CORUM; Q13112; -. DR DIP; DIP-29243N; -. DR FunCoup; Q13112; 2143. DR IntAct; Q13112; 69. DR MINT; Q13112; -. DR STRING; 9606.ENSP00000315700; -. DR GlyGen; Q13112; 2 sites, 1 O-linked glycan (1 site). DR iPTMnet; Q13112; -. DR MetOSite; Q13112; -. DR PhosphoSitePlus; Q13112; -. DR SwissPalm; Q13112; -. DR BioMuta; CHAF1B; -. DR DMDM; 3121829; -. DR jPOST; Q13112; -. DR MassIVE; Q13112; -. DR PaxDb; 9606-ENSP00000315700; -. DR PeptideAtlas; Q13112; -. DR ProteomicsDB; 59163; -. DR Pumba; Q13112; -. DR Antibodypedia; 8327; 324 antibodies from 36 providers. DR DNASU; 8208; -. DR Ensembl; ENST00000314103.6; ENSP00000315700.4; ENSG00000159259.9. DR GeneID; 8208; -. DR KEGG; hsa:8208; -. DR MANE-Select; ENST00000314103.6; ENSP00000315700.4; NM_005441.3; NP_005432.1. DR UCSC; uc002yvj.4; human. DR AGR; HGNC:1911; -. DR ClinPGx; PA26447; -. DR CTD; 8208; -. DR DisGeNET; 8208; -. DR GeneCards; CHAF1B; -. DR HGNC; HGNC:1911; CHAF1B. DR HPA; ENSG00000159259; Tissue enhanced (skeletal). DR MalaCards; CHAF1B; -. DR MIM; 601245; gene. DR OpenTargets; ENSG00000159259; -. DR VEuPathDB; HostDB:ENSG00000159259; -. DR eggNOG; KOG1009; Eukaryota. DR GeneTree; ENSGT00550000074968; -. DR HOGENOM; CLU_010127_5_2_1; -. DR InParanoid; Q13112; -. DR OMA; CTTPEIS; -. DR OrthoDB; 71227at2759; -. DR PAN-GO; Q13112; 3 GO annotations based on evolutionary models. DR PhylomeDB; Q13112; -. DR PathwayCommons; Q13112; -. DR SignaLink; Q13112; -. DR SIGNOR; Q13112; -. DR Agora; ENSG00000159259; -. DR BioGRID-ORCS; 8208; 822 hits in 1153 CRISPR screens. DR ChiTaRS; CHAF1B; human. DR GeneWiki; CHAF1B; -. DR GenomeRNAi; 8208; -. DR Pharos; Q13112; Tbio. DR PRO; PR:Q13112; -. DR Proteomes; UP000005640; Chromosome 21. DR RNAct; Q13112; protein. DR Bgee; ENSG00000159259; Expressed in secondary oocyte and 112 other cell types or tissues. DR GO; GO:0033186; C:CAF-1 complex; IDA:UniProtKB. DR GO; GO:0000785; C:chromatin; IDA:UniProtKB. DR GO; GO:0005737; C:cytoplasm; NAS:UniProtKB. DR GO; GO:0005654; C:nucleoplasm; IDA:HPA. DR GO; GO:0005634; C:nucleus; IBA:GO_Central. DR GO; GO:0032991; C:protein-containing complex; IDA:UniProtKB. DR GO; GO:0003682; F:chromatin binding; TAS:ProtInc. DR GO; GO:0042393; F:histone binding; NAS:UniProtKB. DR GO; GO:0051082; F:unfolded protein binding; TAS:ProtInc. DR GO; GO:0006281; P:DNA repair; IEA:UniProtKB-KW. DR GO; GO:0006260; P:DNA replication; IEA:UniProtKB-KW. DR GO; GO:0006335; P:DNA replication-dependent chromatin assembly; IDA:GO_Central. DR GO; GO:0006334; P:nucleosome assembly; IDA:GO_Central. DR FunFam; 2.130.10.10:FF:000248; Chromatin assembly factor 1 subunit B; 1. DR FunFam; 2.130.10.10:FF:001187; Chromatin assembly factor-1 p105 subunit; 1. DR Gene3D; 2.130.10.10; YVTN repeat-like/Quinoprotein amine dehydrogenase; 2. DR InterPro; IPR055410; Beta-prop_CAF1B_HIR1. DR InterPro; IPR029129; CAF1_p60_C. DR InterPro; IPR045145; PTHR15271. DR InterPro; IPR015943; WD40/YVTN_repeat-like_dom_sf. DR InterPro; IPR001632; WD40_G-protein_beta-like. DR InterPro; IPR019775; WD40_repeat_CS. DR InterPro; IPR036322; WD40_repeat_dom_sf. DR InterPro; IPR001680; WD40_rpt. DR PANTHER; PTHR15271; CHROMATIN ASSEMBLY FACTOR 1 SUBUNIT B; 1. DR PANTHER; PTHR15271:SF4; CHROMATIN ASSEMBLY FACTOR 1 SUBUNIT B; 1. DR Pfam; PF24105; Beta-prop_CAF1B_HIR1; 1. DR Pfam; PF15512; CAF-1_p60_C; 1. DR PRINTS; PR00319; GPROTEINB. DR SMART; SM00320; WD40; 5. DR SUPFAM; SSF50978; WD40 repeat-like; 1. DR PROSITE; PS00678; WD_REPEATS_1; 1. DR PROSITE; PS50082; WD_REPEATS_2; 3. DR PROSITE; PS50294; WD_REPEATS_REGION; 1. PE 1: Evidence at protein level; KW 3D-structure; Acetylation; Cell cycle; Chaperone; Chromatin regulator; KW Cytoplasm; Direct protein sequencing; DNA damage; DNA repair; KW DNA replication; Nucleus; Phosphoprotein; Proteomics identification; KW Reference proteome; Repeat; WD repeat. FT CHAIN 1..559 FT /note="Chromatin assembly factor 1 subunit B" FT /id="PRO_0000050896" FT REPEAT 11..54 FT /note="WD 1" FT REPEAT 64..103 FT /note="WD 2" FT REPEAT 127..166 FT /note="WD 3" FT REPEAT 169..208 FT /note="WD 4" FT REPEAT 228..279 FT /note="WD 5" FT REPEAT 299..340 FT /note="WD 6" FT REPEAT 344..385 FT /note="WD 7" FT REGION 386..559 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 430..444 FT /note="Low complexity" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 469..495 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 509..526 FT /note="Low complexity" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 541..552 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT MOD_RES 394 FT /note="Phosphothreonine" FT /evidence="ECO:0007744|PubMed:23186163" FT MOD_RES 409 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:20068231" FT MOD_RES 419 FT /note="Phosphothreonine" FT /evidence="ECO:0007744|PubMed:18669648, FT ECO:0007744|PubMed:23186163" FT MOD_RES 429 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:18669648, FT ECO:0007744|PubMed:19690332, ECO:0007744|PubMed:23186163" FT MOD_RES 433 FT /note="Phosphothreonine" FT /evidence="ECO:0007744|PubMed:18669648, FT ECO:0007744|PubMed:23186163" FT MOD_RES 458 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:20068231, FT ECO:0007744|PubMed:21406692, ECO:0007744|PubMed:23186163" FT MOD_RES 494 FT /note="N6-acetyllysine" FT /evidence="ECO:0007744|PubMed:19608861" FT MOD_RES 495 FT /note="Phosphothreonine" FT /evidence="ECO:0000255" FT MOD_RES 509 FT /note="Phosphothreonine" FT /evidence="ECO:0000255" FT MOD_RES 521 FT /note="Phosphothreonine" FT /evidence="ECO:0000255" FT MOD_RES 531 FT /note="Phosphothreonine" FT /evidence="ECO:0000255" FT MOD_RES 538 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:18669648" FT VARIANT 506 FT /note="K -> Q (in dbSNP:rs74900401)" FT /id="VAR_053387" FT CONFLICT 494 FT /note="K -> N (in Ref. 5; CAA66915)" FT /evidence="ECO:0000305" FT STRAND 2..5 FT /evidence="ECO:0007829|PDB:7Y5L" FT TURN 10..13 FT /evidence="ECO:0007829|PDB:7Y5L" FT STRAND 16..21 FT /evidence="ECO:0007829|PDB:7Y5L" FT STRAND 27..36 FT /evidence="ECO:0007829|PDB:7Y5L" FT STRAND 41..48 FT /evidence="ECO:0007829|PDB:7Y5L" FT STRAND 50..52 FT /evidence="ECO:0007829|PDB:7Y5L" FT STRAND 54..62 FT /evidence="ECO:0007829|PDB:7Y5L" FT STRAND 69..74 FT /evidence="ECO:0007829|PDB:7Y5L" FT STRAND 76..80 FT /evidence="ECO:0007829|PDB:8IQG" FT STRAND 81..85 FT /evidence="ECO:0007829|PDB:7Y5L" FT STRAND 90..95 FT /evidence="ECO:0007829|PDB:7Y5L" FT STRAND 119..125 FT /evidence="ECO:0007829|PDB:7Y5L" FT STRAND 132..137 FT /evidence="ECO:0007829|PDB:7Y5L" FT STRAND 141..148 FT /evidence="ECO:0007829|PDB:7Y5L" FT STRAND 153..157 FT /evidence="ECO:0007829|PDB:7Y5L" FT TURN 158..161 FT /evidence="ECO:0007829|PDB:7Y5L" FT STRAND 162..167 FT /evidence="ECO:0007829|PDB:7Y5L" FT STRAND 174..179 FT /evidence="ECO:0007829|PDB:7Y5L" FT STRAND 183..190 FT /evidence="ECO:0007829|PDB:7Y5L" FT STRAND 195..199 FT /evidence="ECO:0007829|PDB:7Y5L" FT TURN 200..202 FT /evidence="ECO:0007829|PDB:7Y5L" FT STRAND 204..209 FT /evidence="ECO:0007829|PDB:7Y5L" FT STRAND 211..213 FT /evidence="ECO:0007829|PDB:7Y5L" FT HELIX 218..220 FT /evidence="ECO:0007829|PDB:7Y5L" FT STRAND 224..228 FT /evidence="ECO:0007829|PDB:7Y5L" FT STRAND 246..272 FT /evidence="ECO:0007829|PDB:7Y5L" FT STRAND 274..276 FT /evidence="ECO:0007829|PDB:7Y5L" FT STRAND 278..282 FT /evidence="ECO:0007829|PDB:7Y5L" FT STRAND 288..299 FT /evidence="ECO:0007829|PDB:7Y5L" FT STRAND 309..311 FT /evidence="ECO:0007829|PDB:7Y5K" FT STRAND 314..330 FT /evidence="ECO:0007829|PDB:7Y5L" FT STRAND 338..343 FT /evidence="ECO:0007829|PDB:7Y5L" FT STRAND 349..354 FT /evidence="ECO:0007829|PDB:7Y5L" FT STRAND 358..365 FT /evidence="ECO:0007829|PDB:7Y5L" FT STRAND 366..368 FT /evidence="ECO:0007829|PDB:8IQG" FT STRAND 370..374 FT /evidence="ECO:0007829|PDB:7Y5L" SQ SEQUENCE 559 AA; 61493 MW; AD1846CC81B8DC9F CRC64; MKVITCEIAW HNKEPVYSLD FQHGTAGRIH RLASAGVDTN VRIWKVEKGP DGKAIVEFLS NLARHTKAVN VVRFSPTGEI LASGGDDAVI LLWKVNDNKE PEQIAFQDED EAQLNKENWT VVKTLRGHLE DVYDICWATD GNLMASASVD NTAIIWDVSK GQKISIFNEH KSYVQGVTWD PLGQYVATLS CDRVLRVYSI QKKRVAFNVS KMLSGIGAEG EARSYRMFHD DSMKSFFRRL SFTPDGSLLL TPAGCVESGE NVMNTTYVFS RKNLKRPIAH LPCPGKATLA VRCCPVYFEL RPVVETGVEL MSLPYRLVFA VASEDSVLLY DTQQSFPFGY VSNIHYHTLS DISWSSDGAF LAISSTDGYC SFVTFEKDEL GIPLKEKPVL NMRTPDTAKK TKSQTHRGSS PGPRPVEGTP ASRTQDPSSP GTTPPQARQA PAPTVIRDPP SITPAVKSPL PGPSEEKTLQ PSSQNTKAHP SRRVTLNTLQ AWSKTTPRRI NLTPLKTDTP PSSVPTSVIS TPSTEEIQSE TPGDAQGSPP ELKRPRLDEN KGGTESLDP //